By Benjamin Chiou
Date: Thursday 24 Sep 2026
(Sharecast News) - Shares in CVS Group fell sharply on Thursday after the veterinary services provider reported a decline in statutory profits, as costs associated with the UK competition regulator's investigation weighed on the bottom line and like-for-like sales growth slowed in the second half.
| Transaction in Own Shares | 05-Oct-2026 | 07:00 | RNS |
| TVR & Confirmation of Dividend Dates | 30-Sep-2026 | 07:00 | RNS |
| Transaction in Own Shares | 28-Sep-2026 | 07:00 | RNS |
| PDMR Dealing | 24-Sep-2026 | 16:25 | RNS |
| Final results for the year ended 30 June 2026 | 24-Sep-2026 | 07:00 | RNS |
| Vet chain’s £40m for acquisitions | 22-Dec-2011 | The Scotsman |
| Questor : CVS Group | 21-Oct-2010 | Telegraph |
| Questor:CVS Group | 06-Oct-2009 | Telegraph |
| Tempus:CVS Group | 23-Sep-2009 | Times |
| Oil sector begins recovery | 11-Oct-2007 | Guardian |
| Tempus: CVS Group | 11-Oct-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 1,163.00p |
| Change Today | -7.00p |
| % Change | -0.60 % |
| 52 Week High | 1,424.00 |
| 52 Week Low | 1,114.00 |
| Volume | 284,166 |
| Shares Issued | 67.37m |
| Market Cap | £783.55m |
| Beta | 0.00 |
| RiskGrade | 136 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 9 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 05-Nov-26 | 06-Nov-25 |
| Paid | 04-Dec-26 | 05-Dec-25 |
| Amount | 9.00p | 8.50p |
| Time | Volume / Share Price |
| 16:09 | 50,000 @ 1,171.17p |
| 09:03 | 15,000 @ 1,175.35p |
| 16:36 | 5,000 @ 1,185.58p |
| 16:36 | 5,000 @ 1,185.58p |
| 16:35 | 34,082 @ 1,163.00p |
| CEO | Richard Fairman |
| Finance Director | Robin Alfonso |
You are here: research